Suivre
Tanmoy kanp
Tanmoy kanp
National institute of pharmaceutical research and education, NIPER Hyderabad
Adresse e-mail validée de niperhyd.ac.in
Titre
Citée par
Citée par
Année
Fabrication of amorphous solid dispersion of Entacapone for enhanced solubility and dissolution rate: Morphology, solid state characterization, In silico molecular docking studies
A Dhuri, T Kanp, AVS Sarma, R Nair, P Paul, B Sharma, S Munagalasetty, ...
Journal of Molecular Structure 1324, 140851, 2025
12025
Manifesting the Dasatinib-gallic acid co-amorphous system to augment anticancer potential: Physicochemical characterization, in silico molecular simulation, ex vivo …
T Kanp, A Dhuri, M Aalhate, S Mahajan, S Munagalasetty, SK Sah, S Kaity, ...
International Journal of Pharmaceutics 665, 124672, 2024
12024
Current Advances in Non-viral Nanoparticle-Based Gene Therapy for Effective Management of Cancer.
A Dhuri, T Kanp, K Rode, M Bharath, U Gupta, SK Guru, PK Singh
Journal of Drug Delivery Science and Technology, 106083, 2024
12024
Exploring the Potential of Nanocarriers for Cancer Immunotherapy: Insights into Mechanism, Nanocarriers, and Regulatory Perspectives
T Kanp, A Dhuri, K Rode, M Aalhate, P Paul, R Nair, PK Singh
ACS Applied Bio Materials, 2025
2025
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–4